A Phase II Study of Carboplatin Plus Irinotecan Versus Irinotecan in Children With Refractory Solid Tumors

Completed · Phase 2

Conditions studied: Neoplasms

In brief

This clinical research study is being conducted to investigate the effectiveness of combining carboplatin and irinotecan, versus irinotecan alone, in treating children who have refractory solid tumors.

Key facts

Study ID

NCT00057473

Run by

Bristol-Myers Squibb

Starts

2003-02-01

Expected to finish

2004-02-01

Last updated by the study team

2011-04-14

Who can join

Age: 1 and older, up to 21. Sex: any. Healthy volunteers: not accepted.

Where it is running

• Local Institution — Orlando, Florida, United States
• Local Institution — Houston, Texas, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.